[68Ga]Ga-FAPI-46 has demonstrated efficacy in assessing bleomycin-induced idiopathic pulmonary fibrosis by targeting highly expressed FAP cells, showing promising applications [8]. The gene discussed is FAP; the disease is pulmonary fibrosis.